Brightspec Announces $18.4 Million Financing Round Led By Genoa Ventures And Arboretum Ventures

Dec 14, 2022•about 3 years ago

Amount Raised

$18.4 Million

WalthamresearchInformation Technology

Investors

Uva Seed FundMedvest CapitalArboretum VenturesGenoa Ventures

Description

BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures. The round includes participation from existing investors including Medvest Capital, Felton Group LLC, and the UVA Seed Fund. Jenny Rooke, Ph.D., and Dan Kidle, from Genoa and Arboretum respectively, have joined BrightSpec's Board of Directors.

Company Information

Company

BrightSpec

Location

1466 Main St.

Waltham, Massachusetts, United States

About

BrightSpec is the leading life science tools company commercializing instruments that harness the power of molecular rotational resonance (MRR) spectroscopy. MRR is an innovative approach to rapidly and definitively characterize the unique three-dimensional structure of small molecules, including all forms of structural and spatial isomers. BrightSpec is developing a vertically integrated platform which includes quantum simulation, rotational spectrometers, data analysis tools and automation with the goal of bringing this technology to the forefront of the applied sciences including the pharmaceutical, chemical and consumer goods industries.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends